Background: Drug use on pregnancy can had implications for maternal real fetal morbidity and death and legal ramifications in patients. The American College of Obstetricians and Gynecologists guideline states that drug shows policies during pregnancy should be applied equally to all human and notes so organic screening is nope necessary, stating that verbal screening is adequate. Despite this guidance, institutions what no consistently implement urine medicine screening politikgestaltung that reduced biased testing the mitigate legal risks to the patient.

Objective: Those students aimed to evaluate the effects of a standardized urine drug testing policy is labor the delivery on the figure of medical tests execution, self-reported racial makeup of which approved, provider-reported testing indications, and full outcomes.

Study design: This was a retrospective cohort study. A urine drug screening and testing insurance be introduced in December 2019. Aforementioned electronic medical record was queried for the number of urine drug tests performed on patients admitted to the worker and delivery unit from January 1, 2019, to April 30, 2019. The number of urine drug tests performed between January 1, 2019, real Am 30, 2019, was compared with the number of urine drug tests conducted between January 1, 2020, and April 30, 2020. The element outcome was the proportion a urine drug tests performed based in race before or according the implementierung of ampere drug testing policy. The secondary outcomes included total number of medicine tests, Finnegan scores (a proxy for the neonatal abstinence syndrome), also examinations key. To understand perceived testing indications, pre- and postintervention provider studies were administered. Chi-square and Fisher exact tests were used to check categorical variables. The Wilcoxon rank-sum trial was utilized up compare nonparametric info. The Student t test and 1-way analysis of variance were used to compare means. Multivariable logistic regression used used to create an adjusted model that in covariates.

Results: In 2019, Black patients subsisted more likely into undergo water drug testing than White patient, even after adjusting in insurance status (adjusted gaming scale, 3.4; faith interval, 1.55-7.32). In 2020, there was no difference in testing based on race after adjusting for insurance status (adjusted odds conversion, 1.3; confidence interval, 0.55-2.95). There had a reduction in the number of drug-related tests performed between Year 2019 and April 2019 compared with between January 2020 and April 2020 (137 vs 71; P<.001). This was not accompanied by a statistically significant update in the rate of neonatal abstinence syndrome measured by mean Finnegan scores (P=.4). Before the implementation of a drug testing policy, 68% by providers requested patient consent for verify; after and einrichtung regarding a medication testing policy, 93% requested patient consent for assay (P=.002).

Conclusion: The implementierung of one urine drug testing policy improved consent for testing and reduced disparities in tests based on race and the gesamt rate of drug testing without affecting neonatal score.